Effect of antihypertensive therapy on aortic distensibility in patients with essential hypertension: Comparison with trichlormethiazide, nicardipine and alacepril

Cardiovascular Drugs and Therapy

Volumn 13, Issue 4, 1999, Pages 339-346

  Honda, Toshio ^a   Hamada, Mareomi ^b   Shigematsu, Yuji ^b   Matsumoto, Yuji ^b   Matsuoka, Hiroshi ^b   Hiwada, Kunio ^b  

^a Saiseikai Saijo Hospital   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Aortic distensibility; Calcium antagonist; Diuretic; Essential hypertension

Indexed keywords

ALACEPRIL; NICARDIPINE; TRICHLORMETHIAZIDE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY DILATATION; ARTICLE; ASCENDING AORTA; CLINICAL ARTICLE; DESCENDING AORTA; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULSE PRESSURE;

EID: 0032841991     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007711617112     Document Type: Article

References (46)

1. Belz GG. Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther 1995;9:73-83.
2. Safar ME, London GM. Arterial and venous compliance in sustained essential hypertension. Hypertension 1987;10:133-139.
3. Honda T, Yano K, Matsuoka H, Hamada M, Hiwada K. Evaluation of aortic distensibility in patients with essential hypertension by using cine magnetic resonance imaging. Angiology 1994;45:207-212.
4. Bouthier JD, De Luca N, Safar ME, Simon ACh. Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J 1985;109:1345-1352.
5. Thomson SG. An appraisal of the large-scale trials of antihypertensive treatment. In: Bulpitt CJ, ed. Handbook of Hypertension, Vol. 6: Epidemiology of Hypertension. Amsterdam: Elsevier Science Publishers B.V., 1985;6:331-343.
6. Gribbin B, Pickering TG, Sleight P. Arterial distensibility in normal and hypertensive man. Clin Sci 1979;56:413-417.
7. Schieken RM, Moskowitz WB, Bodurtha J, Mosteller M, Eaves L, Nance W. Aortic stiffness: a new Doppler echocardiographic measure predictive of systolic blood pressure in children. J Am Coll Cardiol 1988;11:1297-1300.
8. Gozna ER, Marble AE, Shaw A, Holland JG. Age-related changes in the mechanics of the aorta and pulmonary artery of man. J Appl Physiol 1971;36:407-411.
9. Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Boudoulas H. Aortic distensibility abnormalities in coronary artery disease. Am J Cardiol 1987;59:1300-1304.
10. Arndt JO, Klauske J, Mersch F. The diameter of the intact carotid artery in man and its change with pulse pressure. Pflugers Arch 1968;301:230-240.
11. Goldberg BB. Suprasternal ultrasonography. JAMA 1971; 215:245-250.
12. Stefanadis C, Stratos C, Vlachopoulos C, et al. Pressure-diameter relation of the human aorta. A new method of determination by the application of a special ultrasonic dimension catheter. Circulation 1995;92:2210-2219.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A-The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
14. Teichholz LE, Kreulen T, Herman MV, Golin R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic collerations in the presence or absence of asynergy. Am J Cardiol 1976;37:7-11.
15. Carlson RG, Lillehei CW, Edwards JE. Cystic medial necrosis of the ascending aorta in relation to age and hypertension. Am J Cardiol 1970;25:411-415.
16. O'Rourke MF. Pulsatile arterial haemodynamics in hypertension. Aust NZ J Med 1976;6(Suppl 2):40-48.
17. Merillon JP, Fontenier GJ, Lerallut JF, et al. Aortic input impedance in normal man and arterial hypertension: Its modification during changes in aortic pressure. Cardiovasc Res 1982;16:646-656.
18. Nichols WW, O'Rourke MF, Avolio AP, Yaginuma T, Pepine CJ, Conti CR. Ventricular/vascular interaction in patients with mild systemic hypertension and normal peripheral resistance. Circulation 1986;74:455-462.
19. Honda T, Hamada M, Matsumoto Y, Matsuoka H, Hiwada K. Noninvasive physiological assessment of vascular wall sclerosis using carotid pulse tracing and cine magnetic resonance. Angiology 1995;46:369-374.
20. Levy BI, Curmi P, Poitevin P, Safar ME. Modifications of the arterial mechanical properties of normotensive and hypertensive rats without arterial pressure changes. J Cardiovasc Pharmacol 1989;14:253-259.
21. Levy BI, Poitevin P, Safer ME. Effects of indapamide on the mechanical properties of the arterial wall in deoxycorticosterone acetate-salt hypertensive rats. Am J Cardiol 1990; 65:28H-32H.
22. Asmar RG, Pannier B, Santoni JP, et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988;78:941-950.
23. Breithaupt-Grogler K, Leschinger M, Belz GG, et al. Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta. Cardiovasc Drugs Ther 1996;10:49-57.
24. Bouthier JD, Safar ME, Benetos A, Simon ACh, Levenson JA, Hugues ChM. Haemodynamic effects of vasodilating drugs on the common carotid and brachial circulations of patients with essential hypertension. Br J Clin Pharmacol 1986;21:137-142.
25. Safar ME, London GM, Bouthier JA, Levenson JA, Laurent St. Brachial artery cross-sectional area and distensibility before and after arteriolar vasodilation in men with sustained essential hypertension. J Cardiovascular Pharmacol 1987;9:734-742.
26. Safar ME, Toto-Moukouo JJ, Bouthier JA, et al. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation 1987;75(Suppl I):I-156-I-161.
27. Safar ME, Pannier B, Laurent S, London GM. Calcium-entry blockers and arterial compliance in hypertension. J Cardiovasc Pharmacol 1989;14(Suppl 10):S1-S6.
28. Yano M, Kumada T, Matsuzaki M, et al. Effect of diltiazem on aortic pressure-diameter relationship in dogs. Am J Physiol 1989;256:H1580-H1587.
29. Berder H. The anatomy and physiology of the vascular wall. Handbook of Physiology. Baltimore: Williams & Wilkins 1962:865-899.
30. Flaim SF. Comparative pharmacology of calcium blockers based on studies of vascular smooth muscle. In: Flaim SF, Zelis R, eds. Calcium Blockers. Mechanisms of Action and Clinical Applications. Baltimore: Urban & Schwarzenberg, 1982:155-178.
31. Kohno M, Kumada T, Ozaki M, et al. Evaluation of aortic wall distensibility by aortic pressure-dimension relation: Effects of nifedipine on aortic wall. Cardiovasc Res 1987;21:305-312.
32. Tend M, Takenaka T, Maeno H. Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93). Biochem Pharmacol 1981;30:375-378.
33. Safar ME, Bouthier JD, Levenson JA, Simon AC. Peripheral large arteries and the response to antihypertensive treatment. Hypertension 1983;5(Suppl III):III-63-III-68.
34. De Luca N, Ricciardelli B, Rosiello G, et al. Stable improvement in large artery compliance after long-term antihypertensive treatment with enalapril. Am J Hypertens 1988;1:181-183.
35. De Luca N, Rosiello G, Lamenza F, et al. Reversal of cardiac and large artery structural abnormalities induced by longterm antihypertensive treatment with trandolapril. Am J Cardiol 1992;70:52D-59D.
36. Benetos A, Vasmant D, Thiery P, Safar M. Effects of ramipril on arterial hemodynamics. J Cardiovasc Pharmacol 1991;18(Suppl 2):S153-S156.
37. Scalbert E, Levy B, Desche P, Devissaguet M, Safar ME. Vascular effects of perindopril: from experimental to clinical investigation. J Cardiovasc Pharmacol 1991;18(Suppl 7): S25-S32.
38. Schartl M, Bocksch WG, Dreysse S, Beckmann S, Franke O, Hunten U. Remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients. J Hypertens 1994;12(Suppl 4):S37-S42.
39. Barenbrock M, Spieker C, Hoeks APG. Zidek W, Rahn KH. Effect of lisinopril and metoprolol on arterial distensibility. Hypertension 1994;23(suppl I):I-161-I-163.
40. Frohlich ED, Sasaki O. Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats. J Am Coll Cardiol 1990;16:1492-1499.
41. Frohlich ED, Horinaka S. Cardiac and aortic effects of angiotensin converting enzyme inhibitors. Hypertension 1991; 18(Suppl II):II-2-II-7.
42. Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990;15:68-77.
43. Levy BI, Benessiano J, Poitevin P, Safar ME. Endothelium-dependent mechanical properties of the carotid artery in WKY and SHR. Role of angiotensin converting engine inhibition. Circ Res 1990;66:321-328.
44. Lee RMKW, Berecek KH, Tsoporis J, MCKenzie R, Triggle CR. Prevention of hypertension and vascular changes by captopril treatment. Hypertension 1991;17:141-150.
45. Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, Unger T. Vascular remodeling in systemic hypertension. Am J Cardiol 1993;71:2E-7E.
46. Kazatani Y, Hamada M, Shigematsu Y, Hiwada K, Kokubu T. Beneficial effect of a long-term antihypertensive therapy on blood pressure response to isometric handgrip exercise in patients with essential hypertension. Am J Therapeut 1995;2:165-169.